Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment

  • Jianya Zhou1Email author,
  • Jing Zheng1,
  • Xiaochen Zhang2,
  • Jing Zhao3,
  • Yanping Zhu1,
  • Qian Shen1,
  • Yuehong Wang1,
  • Ke Sun3,
  • Zeying Zhang1,
  • Zhijie Pan1,
  • Yihong Shen1 and
  • Jianying Zhou1Email author
BMC Cancer201818:10

https://doi.org/10.1186/s12885-017-3720-8

Received: 31 December 2016

Accepted: 30 October 2017

Published: 3 January 2018

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Dec 2016 Submitted Original manuscript
22 Feb 2017 Reviewed Reviewer Report - Herbert Loong
28 Feb 2017 Reviewed Reviewer Report - Christine Fillmore Brainson
9 Jul 2017 Author responded Author comments - Jianya Zhou
Resubmission - Version 2
9 Jul 2017 Submitted Manuscript version 2
14 Sep 2017 Reviewed Reviewer Report - Herbert Loong
8 Oct 2017 Author responded Author comments - Jianya Zhou
Resubmission - Version 3
8 Oct 2017 Submitted Manuscript version 3
Publishing
30 Oct 2017 Editorially accepted
3 Jan 2018 Article published 10.1186/s12885-017-3720-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
(2)
Department of Medical Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
(3)
Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Advertisement